July/August #189 : Mapping Viral and Immune Coevolution - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents


Magnetic Attraction

A Shred of Understanding

Hold Your Horses

From the Editor

Accentuate the Positive


Letters-July/August 2013


Pride and Policy

POZ Planet

Say What?—Alicia Keys

Greetings from Ptown

PACHA Covers Trans Issues

Making Headlines

Latest Developments

Not Another Gay Sex Disease

Future Lovers

On a Roll


Yours in the Struggle

Care and Treatment

The Quest to Cure Another Baby

Viral Suppression Without Drugs?

The Genetic Fusion Inhibitor

New Retention Guidelines Urge Partnerships

Mapping Viral and Immune Coevolution

Research Notes

Prevention: PrEP May Be Cost-Effective

Treatement: Can Bees Sting Away HIV?

Cure: HDAC Inhibitors May Fight HIV Reservoir

Concerns: Hep C Transmission Among Gay Men

POZ Survey Says

Accentuate the Negative

POZ Heroes

Chemical Crusader

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

July / August 2013

Mapping Viral and Immune Coevolution

by Benjamin Ryan

For the first time, scientists have mapped the coevolution of HIV and the corresponding immune response in a single person, which has provided vital clues that may help vaccine development. Investigators sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) analyzed weekly blood samples from one African man beginning four weeks after he was infected and continuing for more than three years.

The researchers were able to chart the virus as it evolved and eventually prompted the man’s immune system to produce what are known as “broadly neutralizing antibodies,” which in his case had the capacity to prevent infection in up to 55 percent of the world’s known HIV strains.

Over the past few years, researchers have made increasing strides in understanding the function and development of these antibodies, which prevent infection by attaching to the virus’s outer envelope and blocking the virus’s entry into cells. About one in five people with HIV will eventually develop broadly neutralizing antibodies after about one to two years, but research suggests they often do so, as in the case of this man, after the viral population has mutated enough to evade the antibodies’ effects. The hope is to develop a vaccine that could harmlessly imitate the virus at pivotal steps in this evolutionary process, prompting the body to produce broadly neutralizing antibodies on its own that block HIV infection.

NIAID director Anthony S. Fauci, MD, says the recent finding is “an important conceptual advance in how you might use a vaccine strategy to guide and coax the immune response along the pathway to a broadly neutralizing antibody.”

Search: National Institute of Allergy and Infectious Diseases, Anthony S. Fauci

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.